Interestingly, an approximately 2% of patients with ALS and primary lateral sclerosis (PLS) carry heterozygous deleterious mutations (nonsynonymous variants) in FIG4 [61], indicating that FIG4 is implicated in the pathogenesis of both peripheral neuropathy and ALS/MNDs. Here, FIG4 is linked to amyotrophic lateral sclerosis.